Skip to main content
. 2019 Jul 3;70(10):2062–2072. doi: 10.1093/cid/ciz589

Figure 4.

Figure 4.

Box plots for HOMA-IR at baseline (0) and 24 weeks by treatment group at the final analysis for continued treatment groups. “A” refers to the control arm; “D” refers to the arm treated with 80 mg of telmisartan. Abbreviation: HOMA-IR, homeostasis model assessment of insulin resistance.